National Institute for Health and Clinical Excellence (NICE)
NICE publishes first rapid COVID-19 guidelines
New guidelines cover the management of patients in critical care, the management of patients who are having kidney dialysis and the management of patients who are receiving systemic anticancer treatments.
NICE has published its first 3 rapid guidelines on the care of people with suspected and confirmed COVID-19, and in patients without COVID-19.
These guidelines have been developed to maximise patient safety whilst making the best use of NHS resources and protecting staff from infection. The guideline has been developed using the interim process and methods for developing rapid guidelines on COVID-19 and recommendations are based on evidence and expert opinion.
COVID-19 rapid guideline: critical care
The guideline on critical care says that all patients on admission to hospital, irrespective of COVID-19 status, should continue to be assessed for frailty using a recognised frailty score (for example, the Clinical Frailty Scale [CFS]).
It also says the risks and benefits and likely outcomes should be discussed with patients, carers or advocates and families using decision support tools (where available) so that they can make informed decisions about their treatment wherever possible.
For patients with confirmed COVID-19, the guideline says decisions about admission to critical care should be made on the basis of medical benefit, taking into account the likelihood that the person will recover to an outcome that is acceptable to them and within a period of time consistent with the diagnosis.
COVID-19 rapid guideline: delivery of systemic anticancer treatments
The rapid guideline on the delivery of systemic anticancer treatments says that where decisions need to be made about prioritising patients for treatment, these need to take into account the level of immunosuppression associated with individual treatments and cancer types, and any other patient-specific risk factors. They should also balance the risk from cancer not being treated optimally versus the risk of becoming seriously ill if they contract COVID-19 because of immunosuppression.
Where changes need to be made to usual care because of system pressures, the guideline says consideration should be given to delivering treatment in different and less immunosuppressive regimens, different locations or via another route of administration.
COVID-19 rapid guideline: dialysis service delivery
The guideline on dialysis says that patients with suspected COVID-19 should be assessed to see whether dialysis could be delayed until their COVID-19 status is known. It also recommends that that outpatient transport services should get patients to their dialysis as scheduled to avoid their condition deteriorating, It should also be ensured that appropriate transport services are available by finding out what current transport providers are prepared to provide, and whether there are alternative providers if the current providers will not transport patients infected with COVID-19.
Further guidelines will be announced in due course but are likely to include: symptom management; patients receiving radiotherapy; and patients with rheumatoid arthritis. NICE will publish new guidelines each week until the full set has been completed, based on the priorities for patients and the NHS.
The guidelines are being produced in collaboration with NHS England/Improvement and a cross-specialty clinical group, supported by the specialist societies and Royal Colleges. NICE will make the guidelines accessible on its website so that health systems around the world can see the approach the UK is taking.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
The key to effective shared decision making is to involve people in meaningful conversations about their choices28/01/2022 16:15:00
"Tell me and I forget. Teach me and I remember. Involve me and I learn." Benjamin Franklin
Selective laser therapy recommended to treat glaucoma and ocular hypertension26/01/2022 15:15:00
People newly diagnosed with glaucoma and ocular hypertension (OHT) should initially be offered selective laser therapy (SLT) treatment rather than eye drops, according to an updated NICE guideline published today (Wednesday, 26 January)
NICE signals commitment to greater flexibility in its evaluation of promising new health technologies and making patient access fairer20/01/2022 14:15:00
Changes to the way medicines and other health technologies are evaluated by NICE for use in the NHS were approved by its Board yesterday (19 January 2022).
Self-harm is everyone’s business, NICE says in new draft guideline19/01/2022 09:15:00
All professionals working across the health and social care system have a role to play in supporting people who self-harm and the issue should not just be seen as the responsibility of those with mental health expertise, NICE has said in a new draft guideline.
Children and young people set to benefit from new treatment for peanut allergy23/12/2021 11:05:00
Children and young people aged between 4 and 17 with a peanut allergy could be set to benefit from Palforzia, a new treatment which can help build up their tolerance to peanut, after NICE recommended its use in draft guidance published today (23 December 2021)
NICE recommends offering PrEP to people at high risk of HIV for first time20/12/2021 13:15:00
People at the highest risk of catching HIV should be offered Pre Exposure Prophylaxis (PrEP), NICE has recommended for the first time.
Over 600 people set to benefit from innovative lung cancer treatment within the Cancer Drugs Fund30/11/2021 12:15:00
More than 600 people could benefit from an innovative drug for a form of lung cancer as NICE publishes final draft guidance recommending osimertinib within the Cancer Drugs Fund
Lessons learned from the multi-agency advisory service – helping developers of AI and data-driven tech to navigate the regulatory pathway25/11/2021 11:15:00
Clíodhna Ní Ghuidhir and Rebecca Boffa outline the common challenges that developers of artificial intelligence (AI) tech face when navigating their way to the health and care market, and link to their series of articles, which provide further advice on what can be done to avoid these.